Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study
Titel:
Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study
Auteur:
Van Cutsem, E. Muro, K. Cunningham, D. Bodoky, G. Sobrero, A. Cascinu, S. Ajani, J. Oh, S.C. Al-Batran, S.E. Wainberg, Z.A. Wijayawardana, S.R. Melemed, S. Ferry, D. Hozak, R.R. Ohtsu, A.